Compare $ACUT vs $BRTX | Chartloom

Compare

$ACUT vs $BRTX

Accustem Sciences Inc · BioRestorative Therapies Inc

ACUT

Accustem Sciences Inc

BRTX

BioRestorative Therapies Inc

Compare $ACUT vs $BRTX

Comparing Accustem Sciences Inc and BioRestorative Therapies Inc

ACUTAccustem Sciences Inc

BRTXBioRestorative Therapies Inc

ACUTAccustem Sciences Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.6%

52W performance

-67.3%

FCF yield

-50.9%

BRTXBioRestorative Therapies Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-8.5%

YTD performance

-92.2%

52W performance

-94.2%

FCF yield

-24.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACUT

BRTX

Detailed metrics comparison

ACUT

Accustem Sciences Inc

BRTX

BioRestorative Therapies Inc

Market Cap

ACUT$2M

BRTX$49M

Enterprise Value

ACUT$2M

BRTX$46M

Price

ACUT$0.15

BRTX$1.91

P/E Ratio

ACUTN/A

BRTXN/A

P/S Ratio

ACUT0.00x

BRTX135.98x

EV/Sales

ACUT0.00x

BRTX127.28x

EV/EBITDA

ACUT0.00x

BRTX0.00x

P/B Ratio

ACUT2.97x

BRTX0.98x

P/FCF Ratio

ACUTN/A

BRTXN/A

EV/FCF

ACUT-2.01x

BRTX-3.83x

PEG Ratio

ACUTN/A

BRTXN/A

Forward P/E (NTM)

ACUTN/A

BRTXN/A

Forward P/S (NTM)

ACUTN/A

BRTXN/A

Revenue (TTM)

ACUT$0

BRTX$358K

Revenue Growth (YoY)

ACUTN/A

BRTX-8.5%

Forward Rev Growth

ACUT0.0%

BRTX64.6%

Gross Margin (TTM)

ACUT0.0%

BRTX92.1%

Operating Margin (TTM)

ACUT0.0%

BRTX0.0%

EBITDA Margin (TTM)

ACUT0.0%

BRTX-3915.8%

Net Margin (TTM)

ACUT0.0%

BRTX-3089.3%

FCF Margin (TTM)

ACUTN/A

BRTX-3324.3%

Net Income (TTM)

ACUT$-2M

BRTX$-11M

FCF (TTM)

ACUT$-1M

BRTX$-12M

EPS (TTM)

ACUT-$0.10

BRTX-$12.47

ROE (TTM)

ACUT-21712.9%

BRTX-42384.0%

ROA (TTM)

ACUT-10530.0%

BRTX-19330.0%

ROIC (TTM)

ACUT-179413.5%

BRTX-42384.0%

Cash

ACUT$13K

BRTX$3M

Debt

ACUT$63K

BRTX$0

Net Cash/Debt

ACUT$-50K

BRTX$3M

Current Ratio (TTM)

ACUT0.02x

BRTX2.35x

Quick Ratio (TTM)

ACUT0.00x

BRTX2.23x

Debt/Equity (TTM)

ACUT0.27x

BRTX0.00x

Debt/Assets (TTM)

ACUT0.0%

BRTX0.0%

Interest Coverage (TTM)

ACUTN/A

BRTXN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

BRTX0.00x

Beta

ACUT1.88

BRTX0.80

52W Performance

ACUT-67.3%

BRTX-94.2%

YTD Performance

ACUT-75.6%

BRTX-92.2%

% from 52W High

ACUT-93.7%

BRTX-94.5%

% from 52W Low

ACUT26.0%

BRTX9.1%

Asset Turnover (TTM)

ACUT0.00x

BRTX0.06x

FCF Yield (TTM)

ACUT-50.9%

BRTX-24.4%

Earnings Yield (TTM)

ACUT-69.8%

BRTX-22.7%

Dividend Yield (TTM)

ACUTN/A

BRTXN/A

Rule of 40

ACUT0.0

BRTX-3,332.8

EV/GP/RG

ACUTN/A

BRTX2.12

Ticker research

View ACUT research View BRTX research

Metric	ACUT Accustem Sciences Inc	BRTX BioRestorative Therapies Inc
Market & Valuation
Market Cap	$2M	$49M
Enterprise Value	$2M	$46M
Price	$0.15	$1.91
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	135.98x
EV/Sales	0.00x	127.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	0.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$358K
Revenue Growth (YoY)	N/A	-8.5%
Forward Rev Growth	0.0%	64.6%
Profitability
Gross Margin (TTM)	0.0%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3915.8%
Net Margin (TTM)	0.0%	-3089.3%
FCF Margin (TTM)	N/A	-3324.3%
Net Income (TTM)	$-2M	$-11M
FCF (TTM)	$-1M	$-12M
EPS (TTM)	-$0.10	-$12.47
ROE (TTM)	-21712.9%	-42384.0%
ROA (TTM)	-10530.0%	-19330.0%
ROIC (TTM)	-179413.5%	-42384.0%
Financial Health
Cash	$13K	$3M
Debt	$63K	$0
Net Cash/Debt	$-50K	$3M
Current Ratio (TTM)	0.02x	2.35x
Quick Ratio (TTM)	0.00x	2.23x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.80
52W Performance	-67.3%	-94.2%
YTD Performance	-75.6%	-92.2%
% from 52W High	-93.7%	-94.5%
% from 52W Low	26.0%	9.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-50.9%	-24.4%
Earnings Yield (TTM)	-69.8%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,332.8
EV/GP/RG	N/A	2.12
Ticker research	View ACUT research	View BRTX research

Valuation

P/S Ratio

ACUT

0.00x

BRTX

135.98x

EV/FCF

BRTX

-3.83x

ACUT

-2.01x

Growth & revenue

Revenue Growth TTM

BRTX

-8.5%

Forward Revenue Growth

BRTX

64.6%

ACUT

0.0%

Profitability & performance

Gross Margin

BRTX

92.1%

ACUT

0.0%

ROE

ACUT

-21712.9%

BRTX

-42384.0%

FCF Yield %

BRTX

-24.4%

ACUT

-50.9%

52-Week Performance

ACUT

-67.3%

BRTX

-94.2%

Detailed metrics comparison

ACUT

Accustem Sciences Inc

BRTX

BioRestorative Therapies Inc

Market Cap

ACUT$2M

BRTX$49M

Enterprise Value

ACUT$2M

BRTX$46M

Price

ACUT$0.15

BRTX$1.91

P/E Ratio

ACUTN/A

BRTXN/A

P/S Ratio

ACUT0.00x

BRTX135.98x

EV/Sales

ACUT0.00x

BRTX127.28x

EV/EBITDA

ACUT0.00x

BRTX0.00x

P/B Ratio

ACUT2.97x

BRTX0.98x

P/FCF Ratio

ACUTN/A

BRTXN/A

EV/FCF

ACUT-2.01x

BRTX-3.83x

PEG Ratio

ACUTN/A

BRTXN/A

Forward P/E (NTM)

ACUTN/A

BRTXN/A

Forward P/S (NTM)

ACUTN/A

BRTXN/A

Revenue (TTM)

ACUT$0

BRTX$358K

Revenue Growth (YoY)

ACUTN/A

BRTX-8.5%

Forward Rev Growth

ACUT0.0%

BRTX64.6%

Gross Margin (TTM)

ACUT0.0%

BRTX92.1%

Operating Margin (TTM)

ACUT0.0%

BRTX0.0%

EBITDA Margin (TTM)

ACUT0.0%

BRTX-3915.8%

Net Margin (TTM)

ACUT0.0%

BRTX-3089.3%

FCF Margin (TTM)

ACUTN/A

BRTX-3324.3%

Net Income (TTM)

ACUT$-2M

BRTX$-11M

FCF (TTM)

ACUT$-1M

BRTX$-12M

EPS (TTM)

ACUT-$0.10

BRTX-$12.47

ROE (TTM)

ACUT-21712.9%

BRTX-42384.0%

ROA (TTM)

ACUT-10530.0%

BRTX-19330.0%

ROIC (TTM)

ACUT-179413.5%

BRTX-42384.0%

Cash

ACUT$13K

BRTX$3M

Debt

ACUT$63K

BRTX$0

Net Cash/Debt

ACUT$-50K

BRTX$3M

Current Ratio (TTM)

ACUT0.02x

BRTX2.35x

Quick Ratio (TTM)

ACUT0.00x

BRTX2.23x

Debt/Equity (TTM)

ACUT0.27x

BRTX0.00x

Debt/Assets (TTM)

ACUT0.0%

BRTX0.0%

Interest Coverage (TTM)

ACUTN/A

BRTXN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

BRTX0.00x

Beta

ACUT1.88

BRTX0.80

52W Performance

ACUT-67.3%

BRTX-94.2%

YTD Performance

ACUT-75.6%

BRTX-92.2%

% from 52W High

ACUT-93.7%

BRTX-94.5%

% from 52W Low

ACUT26.0%

BRTX9.1%

Asset Turnover (TTM)

ACUT0.00x

BRTX0.06x

FCF Yield (TTM)

ACUT-50.9%

BRTX-24.4%

Earnings Yield (TTM)

ACUT-69.8%

BRTX-22.7%

Dividend Yield (TTM)

ACUTN/A

BRTXN/A

Rule of 40

ACUT0.0

BRTX-3,332.8

EV/GP/RG

ACUTN/A

BRTX2.12

Ticker research

View ACUT research View BRTX research

Metric	ACUT Accustem Sciences Inc	BRTX BioRestorative Therapies Inc
Market & Valuation
Market Cap	$2M	$49M
Enterprise Value	$2M	$46M
Price	$0.15	$1.91
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	135.98x
EV/Sales	0.00x	127.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	0.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$358K
Revenue Growth (YoY)	N/A	-8.5%
Forward Rev Growth	0.0%	64.6%
Profitability
Gross Margin (TTM)	0.0%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3915.8%
Net Margin (TTM)	0.0%	-3089.3%
FCF Margin (TTM)	N/A	-3324.3%
Net Income (TTM)	$-2M	$-11M
FCF (TTM)	$-1M	$-12M
EPS (TTM)	-$0.10	-$12.47
ROE (TTM)	-21712.9%	-42384.0%
ROA (TTM)	-10530.0%	-19330.0%
ROIC (TTM)	-179413.5%	-42384.0%
Financial Health
Cash	$13K	$3M
Debt	$63K	$0
Net Cash/Debt	$-50K	$3M
Current Ratio (TTM)	0.02x	2.35x
Quick Ratio (TTM)	0.00x	2.23x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.80
52W Performance	-67.3%	-94.2%
YTD Performance	-75.6%	-92.2%
% from 52W High	-93.7%	-94.5%
% from 52W Low	26.0%	9.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-50.9%	-24.4%
Earnings Yield (TTM)	-69.8%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,332.8
EV/GP/RG	N/A	2.12
Ticker research	View ACUT research	View BRTX research